Respiratory infections
PG2 Postgraduate Course
Multidrug-resistant tuberculosis management in settings with a low tuberculosis incidence
Clinical
Clinical guidance on MDR-TB
Registration for this session is additional to the congress registration fee and is €171 on site, €153 standard.
Aims : To bridge the knowledge gap on MDR-TB existing in high income countries frequently causing misdiagnosis and inaccurate treatment and therefore increasing the possibility of MDR-TB transmission; to describe the most advanced diagnostic and therapeutic tools that are currently available in countries with a low TB incidence, including molecular techniques and new anti-TB drugs.
Target audience :
Clinician, Junior member, Microbiologist, Public health official, Pulmonologist, Respiratory physician, Scientist, TB specialist
Chairs
O. Kon
London
(United Kingdom)
09:30
Epidemiology of MDR-TB in high income countries
D. Falzon(Genève, Switzerland)
COI
-
Description
1
103
10:00
Basic elements of MDR-TB diagnosis
A. Matteelli(Brescia (BS), Italy)
COI
-
Description
2
104
10:30
Group assignment
3
105
11:30
New and repurposed drugs for MDR-TB patients
P. Nahid(San Francisco, United States)
COI
-
Description
5
107
12:00
Management of contact of patients with MDR-TB
R. van Hest(Groningen, Netherlands)
COI
-
Description
6
108
12:30
Group assignment
7
109
. . .
